XML 48 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
Long-Term Obligations and Commitments (Tables)
12 Months Ended
Dec. 31, 2024
Convertible Debt [Abstract]  
Long-Term Obligations

The carrying value of our long-term obligations was as follows (in thousands):

 
December 31,
 
   
2024
   
2023
 
1.75% convertible senior notes
 
$
565,026
   
$
562,285
 
0% convertible senior notes
   
628,535
     
625,380
 
Liability related to sale of future royalties
   
542,212
     
513,736
 
Lease liabilities
   
170,869
     
178,969
 
Mortgage debt
   
8,714
     
8,859
 
Other obligations
   
43,425
     
33,714
 
Total
 
$
1,958,781
   
$
1,922,943
 
Less: current portion
   
(9,279
)
   
(8,831
)
Total Long-Term Obligations
 
$
1,949,502
   
$
1,914,112
 
Convertible Debt [Abstract]  
Debt Maturity Schedules

Annual convertible and mortgage debt maturities, including fixed and determinable interest, at December 31, 2024 are as follows (in thousands):

2025
 
$
10,657
 
2026
   
643,157
 
2027
   
18,737
 
2028
   
580,091
 
2029
   
60
 
Thereafter
   
360
 
Total debt and mortgage maturities
 
$
1,253,062
 
Less: Current portion included in other current liabilities
   
(165
)
Less: Fixed and determinable interest
   
(36,511
)
Less: Debt issuance costs
   
(13,981
)
Total debt
 
$
1,202,405
 
Amounts Related to Operating Leases

Amounts related to our operating leases were as follows (dollar amounts in millions):

 
At December 31, 2024
 
Right-of-use operating lease assets
 
$
161.9
 
Operating lease liabilities
 
$
170.9
 
Weighted average remaining lease term
 
12.1 years
 
Weighted average discount rate
   
6.9
%
Future Payments for Operating Lease Liabilities

As of December 31, 2024, the future payments for our operating lease liabilities are as follows (in thousands):

 
Operating Leases
 
Year ending December 31,
     
2025
 
$
20,870
 
2026
   
21,032
 
2027
   
21,054
 
2028
   
20,973
 
2029
   
18,687
 
Thereafter
   
157,622
 
Total minimum lease payments
   
260,238
 
Less: Imputed interest
   
(89,369
)
Less: Current portion (included in other current liabilities)
   
(9,064
)
Total long-term lease liabilities
 
$
161,805
 
Liability Related to Sale of Future Royalties

The following is a summary of our liability related to sale of future royalties for the year ended December 31, 2024 (in thousands):

Proceeds from sale of future royalties in January 2023
 
$
500,000
 
Issuance costs related to sale of future royalties
   
(10,434
)
Royalty payments to Royalty Pharma
   
(44,628
)
Interest expense related to sale of future royalties
   
68,238
 
Amortization of issuance costs related to sale of future royalties
   
560
 
Net liability related to sale of future royalties as of December 31, 2023
   
513,736
 
Royalty payments to Royalty Pharma
   
(44,981
)
Interest expense related to sale of future royalties
   
72,846
 
Amortization of issuance costs related to sale of future royalties
   
611
 
Net liability related to sale of future royalties as of December 31, 2024
 
$
542,212
 
1.75% Notes [Member]  
Convertible Debt [Abstract]  
Convertible Senior Notes

At December 31, 2024, we had the following 1.75% Notes outstanding (in millions, except interest rate and price per share data):

 
1.75% Notes
 
Outstanding principal balance
 
$
575.0
 
Unamortized debt issuance costs
 
$
10.0
 
Maturity date
 
June 2028
 
Interest rate
   
1.75
%
Effective interest rate
   
2.3
%
Conversion price per share
 
$
53.73
 
Total shares of common stock subject to conversion
   
10.7
 
0% Notes [Member]  
Convertible Debt [Abstract]  
Convertible Senior Notes

At December 31, 2024, we had the following 0% Notes outstanding (in millions, except interest rate and price per share data):

 
0% Notes
 
Outstanding principal balance
 
$
632.5
 
Unamortized debt issuance costs
 
$
4.0
 
Maturity date
 
April 2026
 
Interest rate
   
0
%
Effective interest rate
   
0.5
%
Conversion price per share
 
$
57.84
 
Effective conversion price per share with call spread
 
$
76.39
 
Total shares of common stock subject to conversion
   
10.9